Inhibitory Effects of Gamimahaenggamsuk-tang on RA-related Inflammatory Responses in Cultured Fibroblast-like Synoviocytes |
Jo Jun
(Department of Pathology, College of Oriental Medicine, Daejeon University)
NamGung Uk (Department of Neurophysiology, College of Oriental Medicine, Daejeon University) Kim Soo-Myung (Department of Anatomy, College of Oriental Medicine, Daejeon University) Kang Tak-Lim (Department of Parmacology, College of Oriental Medicine, Daejeon University) Kim Dong-Hee (Department of Pathology, College of Oriental Medicine, Daejeon University) |
1 | Aruoma, O.I. Use of DNA damage as a measure of pro-oxidant actions of antioxidant food additives and nutrient components. In: B. Halliwell and O.I. Aruorna, Editors, DNA and Free Radicals, Ellis Horwood, London, pp 315-327, 1993. |
2 | Huang, W., Li, W.Q., Dehnade, F., Zafarullah, M. Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J. Cell. Biochem. 85, pp 295-303, 2002. |
3 | Jungel, A., Distler, J.H., Kurowska-Stolarska, M., Seemayer, C.A., Seibl, R., Forster, A., Michel, B.A., Gay, RE., Emrnrich, F., Gay, S., Distler, O. Expression of interleukin-21 receptor, but not interleukin-Zl, in synovial fibroblasts and synovial macro phages of patients with rheumatoid arthritis. Arthritis Rheum. 50, pp 1468-1476, 2004. |
4 | Kirwan, J.R. The relationship between synovitis and erosions in rheumatoid arthritis. Br. J. Rheumatol, 36, pp 225-228, 1997. |
5 | Martel-Pelletier, J., Welsch, D.J., Pelletier, J.P. Metalloproteases and inhibitors in arthritic diseases. Best Pract. Res., Clini. Rheumatol. 15, pp 805-829, 2001. |
6 | Melnyk, V.O., Shipley, G.D., Sternfeld, M.D., Sherman, L., Rosenbaum, J.T. Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor. Arthritis Rheum. 33, 493 - 500, 1990. |
7 | Scartezzini, D., Speroni, E. Review on some plants of Indian traditional medicine with antioxidant activity. Journal of Ethnopharmacology. 71, pp 23-43, 2000. |
8 | Schulz, J.B., Lindnau, J., Seyfriend, J., Dichgans, J. Glutathione oxidative stress and neuro-degeneration. European Journal of Biochemistry. 267, pp 4904-4911, 2000. |
9 | Silman, A.J., MacGregor, A.J., Thomson, W., Holligan, S., Carthy, D., Farhan, A, Ollier, W.E. Twin concordance rates for rheumatoid arthritis: results from a nationwidestudy. Br J Rheumatol, 32(10):903-907, 1993. |
10 | Yelin, E., Callahan, L. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum. 38, pp 1351-1362, 1995. |
11 | Pap, T., Muller-Ladner, D., Gay, R.E. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2, pp 361-367, 2000. |
12 | Lee, D.M., Weinblatt, M.E. Rheumatoid arthritis. Lancet. 15, pp 903-911, 2001. |
13 | McCarey, D.W., Mclnnes, I.B., Madhok, R., Hampson, R., Scherbakov, O., Ford, I., Capell, H.A., Sattar, N. Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 363, pp 2015-2021, 2004. |
14 | Pincus, T., Callahan, L.F. What is the natural history of rheumatoid arthritis? Rheumatic Diseases Clinics of North America. 19, pp 123-151, 1993. |
15 | Smeets, T.J., Kraan, M.C., van Loon, M.E. Tumor necrosis factor a blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial cells. Arthritis Rheum. 48, pp 2155-2162, 2003. |
16 | 김호철, 이상인, 안덕균, Human monocyte의 IL-8생산억제에 미치는 류마토이드관절염 치료제로서의 오가피의 효과. 대한본초학회지. 10(1):49-58, 1996. |
17 | Ota, F., Maeshirna, A., Yamashita, S. Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum. 48, pp 2442-2449, 2003. |
18 | Allen, J.B., Manthey, C.L., Hand, A.R. Rapid onset of synovial inflammation and hyperplasia induced by transforming growth factor beta. J. Exp. 171, pp 231-247, 1990. |
19 | Mottonen, T.T. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Annals Rheum Dis. 47, pp 648-665, 1988. |
20 | Konttinen, Y.T., Ainola, M., Valleala, H., Ma, L Ida, H., Mandelin, J., Kinne, R.W., Santavirta, S., Sorsa, T., Lopez-Orin, C., Takagi, M. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 58, pp 691-697, 1999. |
21 | Manabe, N., Oda, H., Nakamura, K. Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients. Rheumatology. 38, pp 714-720, 1999. |
22 | Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., Revillard, J.P. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest. 102, pp 322-328, 1998. |
23 | Ahrens, D., Koch, A.E., Pope, R.M., Stein-Picarella, M., Niedbala, M.J. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 39, pp 1576-1587, 1996. |
24 | Miranda-Cams, M.E., Balsa, A., Benito-Miguel, M., Perez de Ayala, C., Martin-Mola, E. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J. Immunol. 173, pp 1463-1476, 2004. |
25 | Morel, J.C, Park, C.C., Zhu, K. Signal transduction pathways involved in rheumatoid synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-I expression. J. BioI. Chern. 38, pp 34679-34691, 2002. |
26 | Kojima, F., Naraba, H., Sasaki, Y., Beppu, M., Aoki. H., Kawai, S. Prostaglandin E2 is an enhancer of interleukinlbeta-induce expression of membrane-associated prostaglandin E syntase in rheumatoid synovial fibroblasts. Arthritis Rheum. 48, pp 2819-2828, 2003. |
27 | Kontoyiannis, D., Kollias, G. Fibroblast biology. Synovial fibroblasts in rheumatoid arthritis: leading role or chorus line? Arthritis Res. 2, pp 342-343, 2000. |
28 | Krause, D., Schleusser, B., Herborn, G., Rau, R Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis and Rheumatism. 43, pp 14-21, 2000. |
29 | Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai S., Takeuchi, T., Hashimoto, J., Azuma, J., Kishimoto, T. Treatment of rheumatoid arthritis with humanized anti-interleukin-o receptor antibody. Arthritis Rheum. 50, pp 1761-1769, 2004. |
30 | American College of Rheumatology Ad Hoc Committee on Clinical Guidelines, 1Guidelines for the management of rheumatoid arthritis. Arthritis Rheum. 38, pp 713-722, 1996. |
31 | Tak, P.P., Thurkow, E.W., Daha, M.R., Kluin, P.M., Smeets, T.J, Meinders, A.E., Breedveld, F.C. Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol. 77(3):236-242, 1995. |
32 | Aho, K., Koskenvuo, M., Tucminen, J., Kaprio, J. Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13(5):899-902, 1986. |
33 | Gribi, R., Tanaka, T., Harper-Summers, R, Yu, J. Expression of activin A in inflammatory arthropathies. Mol. Cell Endocrinol 180, pp 163-167, 2001. |
34 | Wilske, K.R., Healey, L.A. Remodeling the pyramid: a concept whose time has come. J Rheumatol. 16, pp 505-507, 1989. |
35 | Hwang, S.Y., Kim, J.Y., Kim, K.W., Park, M.K., Moon, Y.,Kim, W.U., Kim, H.Y. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/ Akt-dependent pathways. Arthritis Res. 6, pp 120-128, 2004. |
36 | Plant, M.J., Saklatvala, J., Borg, A.A., Hones, P.W., Dawes, P.T. Measurement and prediction of radiological progression in early rheumatoid arthritis. J Rheumatol. 21, pp 1808-1813, 1994. |
37 | Stransky, G., Vernon, J., Aicher, W.K. Virus-like particles in synovial fluids from patients with rheumatoid arthritis. Br. J. Rheumatol. 32, pp 1044-1048, 1993. |
38 | Dasgupta, B., Corkill, M., Kirkham, B., Gibson, T., Panayi, G. Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J. Rheumatol 19, pp 22-25, 1992. |
39 | Ramsey, S.D., Spencer, A.C., Topolski, T.D., Belza, B., Patrick, D.L. Use of alternative therapies by older adults with osteoarthritis. Arthritis Rheum. 45, pp 222-227, 2001. |
40 | Kramer, I., Wilbulswas, A., Croft, D., Genot, E. Rheumatoid arthritis: targeting the proliferative fibroblast. Prog. Cell Cycle Res. 5, pp 59-70, 2003. |
41 | Wendling, D., Racadot, E., Wijdenes, J. Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J. Rheumatol. 20, pp 259-262, 1993. |